Sanofi S.A., FR0000120578

Sanofi stock after-hours at EUR 70.20: minus 1.29 percent versus Lang & Schwarz prior close

Published on 10/05/2026 at 20:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sanofi stock was at EUR 70.20 after-hours at 8:11 p.m. CEST on October 5, 2026, down 1.29 percent versus the Lang & Schwarz prior close.

Black and white documentary photograph of a female scientist with safety goggles holding a pipette over test tubes in a research laboratory
Sanofi FR0000120578 black-and-white reportage scientist wearing goggles using pipette in pharmaceutical research laboratory, Illustration mit AI erstellt.

Sanofi stock was at EUR 70.20 after-hours at 8:11 p.m. CEST on October 5, 2026, down 1.29 percent versus the prior close of EUR 71.12 at Lang & Schwarz.

Sanofi shares in late trading

The euro price was below the previous session’s Lang & Schwarz close as after-hours trading continued. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Sanofi stock.

Sanofi expands Regeneron alliance

Sanofi and Regeneron announced on October 1, 2026, that they had expanded their antibody collaboration to include four next-generation, long-acting antibodies targeting interleukin-13, an IL-4xIL-13 bispecific, interleukin-4 and interleukin-4 receptor alpha. The announcement was published by GlobeNewswire.

Under the agreement, Regeneron will receive an upfront payment of USD 1.00 billion from Sanofi, with potential development, regulatory and commercial milestone payments of up to an additional USD 7.00 billion. The companies will share development and commercialization costs and split future profits 50:50 globally. Regeneron will lead research and development, while Sanofi will lead global commercial efforts. Sanofi’s investor-relations page records the October 1 conference call on the agreement.

Disclaimer...

en | FR0000120578 | SANOFI S.A. | boerse | 70236002 | bgmi